Agonistic and synergistic activity of tamoxifen in a yeast model system

Biochemical Pharmacology

Volumn 59, Issue 2, 2000, Pages 177-185

  Graumann, Klaus ^a   Jungbauer, Alois ^a  

^a UNIVERSITY OF AGRICULTURAL SCIENCES   (Austria)

Author keywords

agonist; Antagonist; Human estrogen receptor ; Saccharomyces cerevisiae; Tamoxifen; Transcription

Indexed keywords

ESTROGEN RECEPTOR; TAMOXIFEN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG RECEPTOR BINDING; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; TRANSACTIVATION; YEAST;

ANTINEOPLASTIC AGENTS, HORMONAL; BINDING, COMPETITIVE; DRUG SYNERGISM; ESTRADIOL; ESTROGEN ANTAGONISTS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION; HUMANS; MUTATION; RECEPTORS, ESTROGEN; SACCHAROMYCES CEREVISIAE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; TAMOXIFEN; TRANS-ACTIVATION (GENETICS); TRANSFECTION; UBIQUITINS;

EID: 0033990548     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00308-1     Document Type: Article

References (42)

1. Sunderland M.C., Osborne C.K. Tamoxifen in premenopausal patients with metastatic breast cancer A review. J Clin Oncol. 9:1991;1283-1297.
2. Osborne C.K. Mechanisms for tamoxifen resistance in breast cancer Possible role of tamoxifen metabolism. J Steroid Biochem Mol Biol. 47:1993;83-89.
3. Jordan V.C. Studies on the estrogen receptor in breast cancer. Breast Cancer Res Treat. 36:1995;267-285.
4. Klinge C.M., Traish A.M., Bambara R.A., Hilf R. Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA. J Steroid Biochem Mol Biol. 57:1996;51-66.
5. Hedden A., Müller V., Jensen E.V. A new interpretation of antiestrogen action. Ann NY Acad Sci. 761:1995;109-120.
6. McDonnell D.P., Dana S.L., Hoener P.A., Lieberman B.A., Imhof M.O., Stein R.B. Cellular mechanisms which distinguish between hormone- and antihormone-activated estrogen receptor. Ann NY Acad Sci. 761:1995;121-137.
7. Webb P., Lopez G.N., Uht R.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/AP-1 pathway Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol. 9:1995;443-456.
8. McInerney E., Katzenellenbogen B.S. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation. J Biol Chem. 271:1996;24172-24178.
9. Lyttle C.R., Damian-Matsumura P., Juul H., Butt T.R. Human estrogen receptor regulation in a yeast model system and studies on receptor agonists and antagonists. J Steroid Biochem Mol Biol. 42:1992;677-685.
10. Nichols M., Rientjes J.M. Jr, Stewart A.F. Different positioning of the ligand-binding domain helix 12 and the F domain of the estrogen receptor accounts for functional differences between agonists and antagonists. EMBO J. 17:1998;765-773.
11. Katzenellenbogen J.A., O'Malley B.W., Katzenellenbogen B.S. Tripartite steroid hormone receptor pharmacology Interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol. 10:1996;119-131.
12. Butt T.R., Khan M.I., Marsh J.A., Ecker D.J., Crooke S.T. Ubiquitin-metallothionein fusion protein expression in yeast. A genetic approach for analysis of ubiquitin functions. J Biol Chem. 263:1988;16364-16371.
13. Butt T.R., Jonnalagadda S., Monia B.P., Sternberg E.J., Marsh J.A., Stadel J.M., Ecker D.J., Crooke S.T. Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli. Proc Natl Acad Sci USA. 86:1989;2540-2544.
14. Ecker D.J., Stadel J.M., Butt T.R., Marsh J.A., Monia B.P., Powers D.A., Gorman J.A., Clark P.E., Shatzman A., Crooke S.T. Increasing gene expression in yeast by fusion to ubiquitin. J Biol Chem. 264:1989;7715-7719.
15. Graumann K., Wittliff J.L., Raffelsberger W., Miles L., Jungbauer A., Butt T.R. Structural and functional analysis of N-terminal point mutants of the human estrogen receptor. J Steroid Biochem Mol Biol. 57:1996;293-300.
16. McDonnell D.P., Nawaz Z., O'Malley B.W. In situ distinction between steroid receptor binding and transactivation at a target gene. Mol Cell Biol. 11:1991;4350-4355.
17. Bachmair A., Finley D., Varshavsky A. In vivo half-life of a protein is a function of its amino-terminal residue. Science. 234:1986;179-186.
18. Ito H., Fukuda Y., Murata K., Kimura J. Transformation of intact yeast cells treated with alkali cations. J Bacteriol. 153:1983;163-168.
19. Hill J., Donald K.A., Griffiths D.E. DMSO-enhanced whole cell yeast transformation. Nucleic Acids Res. 19:1991;5791.
20. Miller J.H. Experiments in Molecular Genetics. 1972;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
21. Wittliff J.L., Wenz L.L., Dong J., Nawaz Z., Butt T.R. Expression and characterization of an active human estrogen receptor as a ubiquitin fusion protein from Escherichia coli. J Biol Chem. 265:1990;22016-22022.
22. Graumann K, Wittliff JL, Raffelsberger W, Butt TR and Jungbauer A, N-terminal mutations of the human estrogen receptor-α gene alter expression and function of its protein product. Endocrine, submitted.
23. Tzukerman M.T., Esty A., Santiso-Mere D., Danielian P., Parker M.G., Stein R.B., Pike J.W., McDonnell D.P. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 8:1994;21-30.
24. Watanabe T., Inoue S., Ogawa S., Ishii Y., Hiroi H., Ikeda K., Orimo A., Muramatsu M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype Functional difference between estrogen receptors α and β Biochem Biophys Res Commun. 236:1997;140-145.
25. Cavaillès V, Dauvois S, Danielian PS and Parker MG, Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A 91: 10019-10013, 1994.
26. Mattick S., Glenn K., de Haan G., Shapiro D.J. Analysis of ligand dependence and hormone response element synergy in transcription by estrogen receptor. J Steroid Biochem Mol Biol. 60:1997;285-294.
27. Metzger D., White J.H., Chambon P. The human oestrogen receptor functions in yeast. Nature. 334:1988;31-36.
28. Lyman S.D., Jordan V.C. Metabolism of tamoxifen and its uterotrophic activity. Biochem Pharmacol. 34:1985;2787-2794.
29. Saceda M., Lindsey R.K., Solomon H., Angeloni S.V., Martin M.B. Estradiol regulates estrogen receptor mRNA stability. J Steroid Biochem Mol Biol. 66:1998;113-120.
30. Robertson J.A., Bhattacharyya S., Ing N.H. Tamoxifen up-regulates oestrogen receptor-α, c-fos and glyceraldehyde 3-phosphate-dehydrogenase mRNAs in ovine endometrium. J Steroid Biochem Mol Biol. 67:1998;285-292.
31. Beck C.A., Weigel N.L., Edwards D.P. Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. Mol Endocrinol. 6:1992;607-620.
32. Ali S., Metzger D., Bornert J.M., Chambon P. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human estrogen receptor A/B region. EMBO J. 12:1993;1153-1160.
33. Le Goff P., Montano M.M., Schodin D.J., Katzenellenbogen B.S. Phosphorylation of the human estrogen receptor. J Biol Chem. 269:1994;4458-4466.
34. Sasson S., Notides A.C. Estriol and estrone interaction with the estrogen receptor. J Biol Chem. 248:1983;8113-8117.
35. Klinge C.M., Peale F.V. Jr, Hilf R., Bambara R.A., Zain S. Cooperative estrogen receptor interaction with consensus or variant estrogen responsive elements in vitro. Cancer Res. 52:1992;1073-1081.
36. Anolik J.H., Klinge C.M., Hilf R., Bambara R.A. Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand. Biochemistry. 34:1995;2511-2520.
37. Cheskis B.J., Karathanasis S., Lyttle C.R. Estrogen receptor ligands modulate its interaction with DNA. J Biol Chem. 272:1997;11384-11391.
38. Fujimoto N., Katzenellenbogen B.S. Alteration in the agonist/antagonist balance of antiestrogens by activation of protein kinase A signaling pathways in breast cancer cells Antiestrogen selectivity and promoter dependence. Mol Endocrinol. 8:1994;296-304.
39. Castano E., Chen C.W., Vorojeikina D.P., Notides A.C. The role of phosphorylation in human estrogen receptor function. J Steroid Biochem Mol Biol. 65:1998;101-110.
40. Zysk J.R., Johnson B., Ozenberger B.A., Bingham B., Gorski J. Selective uptake of estrogenic compounds by Saccharomyces cerevisiae A mechanism for antiestrogen resistance in yeast expressing the mammalian estrogen receptor. Endocrinology. 136:1995;1323-1326.
41. Metzger D., Ali S., Bornert J.M., Chambon P. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem. 270:1995;9535-9542.
42. Spatz M., Waisman A., Kaye A.M. Responsiveness of the 5′-flanking region of brain type isozyme of creatine kinase to estrogens and antiestrogens. J Steroid Biochem Mol Biol. 41:1992;711-714.